Initial in vitro screening approach to investigate the potential health and environmental hazards of Envirox™ - A nanoparticulate cerium oxide diesel fuel additive

被引：56

作者：

Park B. ^{[1
]}

Martin P. ^{[2
]}

Harris C. ^{[1
]}

Guest R. ^{[3
]}

Whittingham A. ^{[3
]}

Jenkinson P. ^{[3
]}

Handley J. ^{[3
]}

机构：

[1] Oxonica, Yarnton, Oxfordshire

[2] Product Assessment and Regulatory Compliance, Cradley Heath, West Midlands, Sydney Road

[3] SafePharm Laboratories Ltd., Shardlow, Derby, London Road

来源：

Particle and Fibre Toxicology | / 4卷 / 1期

关键词：

Cerium Oxide; Diesel Fuel; Revertant Coloni; Nanoparticulate Cerium Oxide; Hazard Identification;

D O I：

10.1186/1743-8977-4-12

中图分类号：

学科分类号：

摘要：

Nanotechnology is the new industrial revolution of the 21st Century as the various processes lead to radical improvements in medicine, manufacturing, energy production, land remediation, information technology and many other everyday products and applications. With this revolution however, there are undoubted concerns for health, safety and the environment which arise from the unique nature of materials and processes at the nanometre scale. The in vitro assays used in the screening strategy are all validated, internationally accepted protocols and provide a useful indication of potential toxicity of a chemical as a result of effects on various toxicological endpoints such as local site of contact (dermal) irritation, general cytotoxicity and mutagenicity. The initial in vitro screening strategy described in this paper to investigate the potential health implications, if any, which may arise following exposure to one specific application of nanoparticulate cerium oxide used as a diesel fuel borne catalyst, reflects a precautionary approach and the results will inform judgement on how best to proceed to ensure safe use. © 2007 Park et al; licensee BioMed Central Ltd.

引用

共 24 条

[1]

Colvin V., Point of impact: Where technology collides with society, business, and personal lives, Technol Rev, 106, pp. 71-73, (2003)

[2]

Donaldson K., Tran C., Inflammation caused by particles and fibres, Inhal Toxicol, 14, pp. 5-27, (2002)

[3]

Oberdorster G., Oberdorster E., Oberdorster J., Nanotoxicology: An emerging discipline evolving from studies of ultrafine particles, Environ Health Perspect, 113, 7, pp. 823-839, (2005)

[4]

Nanoscience and Nanotechnologies: Opportunities and Uncertainties, (2004)

[5]

Industrial Application of Nanomaterials - Chances and Risks, pp. 1436-5928, (2004)

[6]

A scoping study to identify exposure data needs for addressing the risks presented by nanoparticles and nanotubes, (2005)

[7]

A scoping study to identify hazard data needs for addressing the risks presented by nanoparticles and nanotubes, Institute of Occupational Medicine Research Report, (2005)

[8]

Oberdorster G., Maynard A., Donaldson K., Castranova V., Fitzpatrick J., Ausman K., Carter J., Karn B., Kreyling W., Lai D., Olin S., Monteiro-Riviere N., Warheit D., Yang H., Principles for characterising the potential human health effects from exposure to nanomaterials: Elements of a screening strategy. A report from the ILSI Research Foundation/Risk Science Institute, Particle & Fibre Toxicol, 2, (2005)

[9]

Research Strategies for safety evaluation of nanomaterials. Parts I - V, Toxicol Sci, pp. 87-90, (2005)

[10]

Fallerl C., Barcher M., Dami N., Roguet R., Predictive ability of reconstructed human epidermis equivalents for the assessment of skin irritation of cosmetics, Toxicol in Vitro, 16, pp. 557-572, (2002)

← 1 2 3 →